Datu, Baby Boy D.

HRN: 28-88-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/19/2026
04/26/2026
IV
44mg
Q24
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: